Literature DB >> 14163964

ANTIRABIES ANTIBODY RESPONSE IN MAN TO VACCINE MADE FROM INFECTED SUCKLING-MOUSE BRAINS.

E FUENZALIDA, R PALACIOS, J M BORGONO.   

Abstract

Antirabies vaccines produced from infected brains of adult mammals have always had the potentiality of causing post-vaccinal paralysis or allergic encephalitis in man. Attempts in recent years either to remove the paralytic factor from brain-tissue vaccines or to use as the virus source infected tissue other than nervous tissue (e.g., chick embryos) have usually resulted in a substantial reduction of the specific antirabies potency.The authors' laboratory had previously developed a vaccine made from infected suckling-mouse brains in which the virus was inactivated by ultraviolet irradiation. This vaccine was found highly potent in animal tests and low in organ-specific antigens. Others have found the brains of newborn mammals to be free of the allergic encephalitic factor. The studies reported in this paper show that the antirabies antibody responses to a 14-dose course of this suckling-mouse-brain vaccine in children are at a high level even when the vaccine is used at a 1% tissue concentration. There was no evidence of deleterious reactions to this treatment in 31 children.It is concluded that these results justify a long-term trial of this vaccine for antirabies prophylaxis in man.

Entities:  

Keywords:  BRAIN; CHICK EMBRYO; CHILE; COMPLEMENT FIXATION TESTS; ENCEPHALITIS; MICE; NEUTRALIZATION TESTS; PARALYSIS; RABBITS; RABIES VACCINE; RABIES VIRUS; TISSUE CULTURE; ULTRAVIOLET RAYS; VIRUS CULTIVATION

Mesh:

Substances:

Year:  1964        PMID: 14163964      PMCID: PMC2554821     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  Benzene-inactivated rabies vaccine.

Authors:  K HABEL; J F BELL; J T WRIGHT
Journal:  Proc Soc Exp Biol Med       Date:  1949-03

2.  Avianized rabies virus vaccination in man.

Authors:  M P SCHWAB; J P FOX; D P CONWELL; T A ROBINSON
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

3.  Duck-embryo rabies vaccine; study of fixed virus vaccine grown in embryonated duck eggs and killed with beta-propiolactone (BPL).

Authors:  C G CULBERTSON; F B PECK; H M POWELL
Journal:  J Am Med Assoc       Date:  1956-12-08

4.  Study of antirabies immunization of man; observations with HEP Flury and other vaccines, with and without hyperimmune serum, in primary and recall immunizations.

Authors:  J P FOX; H KOPROWSKI; D P CONWELL; J BLACK; H M GELFAND
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

5.  THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS.

Authors:  E A Kabat; A Wolf; A E Bezer
Journal:  J Exp Med       Date:  1947-01-01       Impact factor: 14.307

6.  Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys.

Authors:  E A KABAT; A WOLF; A E BEZER
Journal:  J Exp Med       Date:  1948-10-01       Impact factor: 14.307

  6 in total
  10 in total

1.  "Living versus dead": The Pasteurian paradigm and imperial vaccine research.

Authors:  Pratik Chakrabarti
Journal:  Bull Hist Med       Date:  2010       Impact factor: 1.314

2.  Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG.

Authors:  Jun Peng; Li Chen; Zheng-Gang Zhu; Ze-Rong Zhu; Quan Hu; Yuan Fang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Rabies vaccines--an assessment.

Authors:  C Kaplan
Journal:  Proc R Soc Med       Date:  1971-02

4.  An allergen-free antirabies vaccine.

Authors:  G J Svet-Moldavskij; O G Andjaparidze; S S Unanov; M K Karakajumcan; I A Svet-Moldavskaja; L S Mucnik; M A Hieninson; L I Ravkina; A A Mtvarelidze; O F Volkova; M R Kriegshaber; A G Kalinkina; T V Salita; V I Klimovickaja; I N Bondaletova; V M Rojheĺ; I S Kiseleva; E N Levcenko; S S Marennikova; S L Leonidova
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

5.  Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine.

Authors:  R K Sikes; W F Cleary; H Koprowski; T J Wiktor; M M Kaplan
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

6.  Purified rabies vaccine (suckling rat brain origin).

Authors:  J F Lavender
Journal:  Appl Microbiol       Date:  1970-06

Review 7.  Developments in rabies vaccines.

Authors:  D J Hicks; A R Fooks; N Johnson
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

Review 8.  Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential.

Authors:  Shimao Zhu; Caiping Guo
Journal:  Viruses       Date:  2016-10-28       Impact factor: 5.048

Review 9.  Four Thousand Years of Concepts Relating to Rabies in Animals and Humans, Its Prevention and Its Cure.

Authors:  Arnaud Tarantola
Journal:  Trop Med Infect Dis       Date:  2017-03-24

Review 10.  Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms.

Authors:  A El-Sayed
Journal:  Int J Vet Sci Med       Date:  2018-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.